LPL and fatty liver disease: Hepatic steatosis, modulation of the expression of genes involved in lipid metabolism (ppars, lpl, fasn, hsl) mostly using NP+t-OP or BPA+NP. Effects milder than those obtained with one chemical (hypothesis of possible interactions among compounds).